慢性阻燃性咳: 咳抑制治疗后的长期结果
Ethan Simmons1, Jessica F Kim1, Daniel DeChance1
1School of Medicine, Loma Linda University, Loma Linda, California.
Journal of voice : official journal of the Voice Foundation
|December 6, 2023
概括
咳抑制疗法 (CST) 有效地减少长期慢性难治性咳 (CRC). 患者在治疗后保持了咳严重程度的降低,表明CST是控制CRC的令人满意的方法.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 肺部病理学 肺部病理学
- 行为疗法是一种行为疗法.
背景情况:
- 慢性难治性咳 (CRC) 显著影响生活质量.
- 对于行为治疗的客观长期结果数据,如CRC的咳抑制疗法 (CST),是有限的.
研究的目的:
- 评估慢性难治性咳 (CRC) 患者咳抑制疗法 (CST) 的长期疗效.
- 为了评估咳减轻严重程度和语音质量的持久性,在CST后随着时间推移.
主要方法:
- 对106名患有CRC的成年患者进行了回顾性图表审查,确定了24名患者,在CST后至少有3个月的随访数据.
- 使用耳鼻喉学评估,语音障碍指数-10 (VHI-10) 和咳严重性指数 (CSI) 评分进行治疗前,治疗后和长期随访评估.
- 分析了基于并发症数量的数据,以探索潜在的相关性.
主要成果:
- 在24名患者中,有20名患者在CST后明显减少了咳严重程度 (P < 0.001).
- 咳严重性指数 (CSI) 的得分显示,从治疗前到长期随访期间的显著改善 (P = 0.001).
- 在治疗后和长期随访期间,CSI或VHI-10得分没有显著变化,这表明持续改善. 在并发症和咳/声音严重程度之间没有发现相关性.
结论:
- 咳抑制疗法 (CST) 对大多数患者来说,导致慢性难治性咳 (CRC) 的长期持续改善.
- 患者可以长期保持咳严重程度的降低,这表明CST提供了持久的好处.
- 伴随性疾病的数量没有显著影响长期咳或语音结果在患者治疗的CST.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
297
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
297
COPD: Pathogenesis and Clinical Features
292
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
292


